CD5 and cancer: Although the virus can infect diverse immune cell populations, including CD5+ and CD5-B lymphocytes, monocytes, and both T helper and cytotoxic lymphocytes, BLV-related cancers predominantly develop from a specific type of B cell, those expressing CD5 and IgM [8].